Amylinergic control of food intake in lean and obese rodents

Physiology and Behavior

Volumn 105, Issue 1, 2011, Pages 129-137

  Boyle, Christina N ^a   Lutz, Thomas A ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Adiposity; Amylin; High fat; Hyperamylinemia; Reward; Satiation

Indexed keywords

AMYLIN; CHOLECYSTOKININ; LEPTIN;

AREA POSTREMA; ARTICLE; FOOD INTAKE; HORMONE ACTION; HORMONE BINDING; HORMONE RELEASE; LEAN BODY WEIGHT; LIPID DIET; MOLECULAR PATHOLOGY; NEUROPATHOLOGY; NONHUMAN; OBESITY; PRIORITY JOURNAL; SATIETY;

ANIMALS; DIET, HIGH-FAT; EATING; HYPOTHALAMUS; ISLET AMYLOID POLYPEPTIDE; NEURONS; OBESITY; RATS; SATIATION;

EID: 79957645885     PISSN: 00319384     EISSN: 1873507X     Source Type: Journal    
DOI: 10.1016/j.physbeh.2011.02.015     Document Type: Article

References (120)

1. Levin B.E. Central regulation of energy homeostasis intelligent design: how to build the perfect survivor. Obesity (Silver Spring) 2006, 14(Suppl 5):192S-196S.
2. Zhang Y., Proenca R., Maffei M., Barone M., Leopold L., Friedman J.M. Positional cloning of the mouse obese gene and its human homologue. Nature 1994, 372:425-432.
3. Halaas J.L., Gajiwala K.S., Maffei M., Cohen S.L., Chait B.T., Rabinowitz D., et al. Weight-reducing effects of the plasma protein encoded by the obese gene. Science 1995, 269:543-546.
4. Vaisse C., Halaas J.L., Horvath C.M., Darnell J.E., Stoffel M., Friedman J.M. Leptin activation of Stat3 in the hypothalamus of wild-type and ob/ob mice but not db/db mice. Nat Genet 1996, 14:95-97.
5. Elmquist J.K., Bjorbaek C., Ahima R.S., Flier J.S., Saper C.B. Distributions of leptin receptor mRNA isoforms in the rat brain. J Comp Neurol 1998, 395:535-547.
6. Munzberg H. Leptin-signaling pathways and leptin resistance. Forum Nutr 2010, 63:123-132.
7. Mercer J.G., Hoggard N., Williams L.M., Lawrence C.B., Hannah L.T., Morgan P.J., et al. Coexpression of leptin receptor and preproneuropeptide Y mRNA in arcuate nucleus of mouse hypothalamus. J Neuroendocrinol 1996, 8:733-735.
8. Cheung C.C., Clifton D.K., Steiner R.A. Proopiomelanocortin neurons are direct targets for leptin in the hypothalamus. Endocrinology 1997, 138:4489-4492.
9. Mizuno T.M., Kleopoulos S.P., Bergen H.T., Roberts J.L., Priest C.A., Mobbs C.V. Hypothalamic pro-opiomelanocortin mRNA is reduced by fasting and [corrected] in ob/ob and db/db mice, but is stimulated by leptin. Diabetes 1998, 47:294-297.
10. Schwartz M.W., Seeley R.J., Woods S.C., Weigle D.S., Campfield L.A., Burn P., et al. Leptin increases hypothalamic pro-opiomelanocortin mRNA expression in the rostral arcuate nucleus. Diabetes 1997, 46:2119-2123.
11. Schwartz M.W., Baskin D.G., Bukowski T.R., Kuijper J.L., Foster D., Lasser G., et al. Specificity of leptin action on elevated blood glucose levels and hypothalamic neuropeptide Y gene expression in ob/ob mice. Diabetes 1996, 45:531-535.
12. Bates S.H., Stearns W.H., Dundon T.A., Schubert M., Tso A.W., Wang Y., et al. STAT3 signalling is required for leptin regulation of energy balance but not reproduction. Nature 2003, 421:856-859.
13. Minokoshi Y., Alquier T., Furukawa N., Kim Y.B., Lee A., Xue B., et al. AMP-kinase regulates food intake by responding to hormonal and nutrient signals in the hypothalamus. Nature 2004, 428:569-574.
14. Hayes M.R., Skibicka K.P., Bence K.K., Grill H.J. Dorsal hindbrain 5'-adenosine monophosphate-activated protein kinase as an intracellular mediator of energy balance. Endocrinology 2009, 150:2175-2182.
15. El-Haschimi K., Pierroz D.D., Hileman S.M., Bjorbaek C., Flier J.S. Two defects contribute to hypothalamic leptin resistance in mice with diet-induced obesity. J Clin Invest 2000, 105:1827-1832.
16. Levin B.E., Dunn-Meynell A.A., Balkan B., Keesey R.E. Selective breeding for diet-induced obesity and resistance in Sprague-Dawley rats. Am J Physiol 1997, 273:R725-R730.
17. Ricci M.R., Levin B.E. Ontogeny of diet-induced obesity in selectively bred Sprague-Dawley rats. Am J Physiol Regul Integr Comp Physiol 2003, 285:R610-R618.
18. Irani B.G., Dunn-Meynell A.A., Levin B.E. Altered hypothalamic leptin, insulin, and melanocortin binding associated with moderate-fat diet and predisposition to obesity. Endocrinology 2007, 148:310-316.
19. Levin B.E., Dunn-Meynell A.A., Banks W.A. Obesity-prone rats have normal blood-brain barrier transport but defective central leptin signaling before obesity onset. Am J Physiol Regul Integr Comp Physiol 2004, 286:R143-R150.
20. Levin B.E., Dunn-Meynell A.A., Ricci M.R., Cummings D.E. Abnormalities of leptin and ghrelin regulation in obesity-prone juvenile rats. Am J Physiol Endocrinol Metab 2003, 285:E949-E957.
21. Zabolotny J.M., Bence-Hanulec K.K., Stricker-Krongrad A., Haj F., Wang Y., Minokoshi Y., et al. PTP1B regulates leptin signal transduction in vivo. Dev Cell 2002, 2:489-495.
22. Munzberg H., Flier J.S., Bjorbaek C. Region-specific leptin resistance within the hypothalamus of diet-induced obese mice. Endocrinology 2004, 145:4880-4889.
23. White C.L., Whittington A., Barnes M.J., Wang Z., Bray G.A., Morrison C.D. HF diets increase hypothalamic PTP1B and induce leptin resistance through both leptin-dependent and -independent mechanisms. Am J Physiol Endocrinol Metab 2009, 296:E291-E299.
24. Banks W.A. Leptin transport across the blood-brain barrier: implications for the cause and treatment of obesity. Curr Pharm Des 2001, 7:125-133.
25. Banks W.A., DiPalma C.R., Farrell C.L. Impaired transport of leptin across the blood-brain barrier in obesity. Peptides 1999, 20:1341-1345.
26. Van Heek M., Compton D.S., France C.F., Tedesco R.P., Fawzi A.B., Graziano M.P., et al. Diet-induced obese mice develop peripheral, but not central, resistance to leptin. J Clin Invest 1997, 99:385-390.
27. Banks W.A., Coon A.B., Robinson S.M., Moinuddin A., Shultz J.M., Nakaoke R., et al. Triglycerides induce leptin resistance at the blood-brain barrier. Diabetes 2004, 53:1253-1260.
28. Horvath T.L. Synaptic plasticity in energy balance regulation. Obesity (Silver Spring) 2006, 14(Suppl 5):228S-233S.
29. Pinto S., Roseberry A.G., Liu H., Diano S., Shanabrough M., Cai X., et al. Rapid rewiring of arcuate nucleus feeding circuits by leptin. Science 2004, 304:110-115.
30. Horvath T.L., Sarman B., Garcia-Caceres C., Enriori P.J., Sotonyi P., Shanabrough M., et al. Synaptic input organization of the melanocortin system predicts diet-induced hypothalamic reactive gliosis and obesity. Proc Natl Acad Sci USA 2010, 107:14875-14880.
31. Bouret S.G., Draper S.J., Simerly R.B. Trophic action of leptin on hypothalamic neurons that regulate feeding. Science 2004, 304:108-110.
32. Bouret S.G., Simerly R.B. Development of leptin-sensitive circuits. J Neuroendocrinol 2007, 19:575-582.
33. Bouret S.G., Gorski J.N., Patterson C.M., Chen S., Levin B.E., Simerly R.B. Hypothalamic neural projections are permanently disrupted in diet-induced obese rats. Cell Metab 2008, 7:179-185.
34. Patterson C.M., Bouret S.G., Park S., Irani B.G., Dunn-Meynell A.A., Levin B.E. Large litter rearing enhances leptin sensitivity and protects selectively bred diet-induced obese rats from becoming obese. Endocrinology 2010, 151:4270-4279.
35. Gibbs J., Young R.C., Smith G.P. Cholecystokinin decreases food intake in rats. J Comp Physiol Psychol 1973, 84:488-495.
36. Woods S.C., Lutz T.A., Geary N., Langhans W. Pancreatic signals controlling food intake; insulin, glucagon and amylin. Philos Trans R Soc Lond B Biol Sci 2006, 361:1219-1235.
37. Lieverse R.J., Jansen J.B., Masclee A.A., Lamers C.B. Satiety effects of a physiological dose of cholecystokinin in humans. Gut 1995, 36:176-179.
38. Covasa M., Ritter R.C. Rats maintained on high-fat diets exhibit reduced satiety in response to CCK and bombesin. Peptides 1998, 19:1407-1415.
39. Covasa M., Ritter R.C. Reduced sensitivity to the satiation effect of intestinal oleate in rats adapted to high-fat diet. Am J Physiol 1999, 277:R279-R285.
40. Covasa M., Grahn J., Ritter R.C. High fat maintenance diet attenuates hindbrain neuronal response to CCK. Regul Pept 2000, 86:83-88.
41. Young A., Denaro M. Roles of amylin in diabetes and in regulation of nutrient load. Nutrition 1998, 14:524-527.
42. Reda T.K., Geliebter A., Pi-Sunyer F.X. Amylin, food intake, and obesity. Obes Res 2002, 10:1087-1091.
43. Lutz T.A., Geary N., Szabady M.M., Del Prete E., Scharrer E. Amylin decreases meal size in rats. Physiol Behav 1995, 58:1197-1202.
44. Rushing P.A., Hagan M.M., Seeley R.J., Lutz T.A., Woods S.C. Amylin: a novel action in the brain to reduce body weight. Endocrinology 2000, 141:850-853.
45. Lutz T.A., Althaus J., Rossi R., Scharrer E. Anorectic effect of amylin is not transmitted by capsaicin-sensitive nerve fibers. Am J Physiol 1998, 274:R1777-R1782.
46. Lutz T.A., Senn M., Althaus J., Del Prete E., Ehrensperger F., Scharrer E. Lesion of the area postrema/nucleus of the solitary tract (AP/NTS) attenuates the anorectic effects of amylin and calcitonin gene-related peptide (CGRP) in rats. Peptides 1998, 19:309-317.
47. Young A. Inhibition of gastric emptying. Adv Pharmacol 2005, 52:99-121.
48. Mollet A., Gilg S., Riediger T., Lutz T.A. Infusion of the amylin antagonist AC 187 into the area postrema increases food intake in rats. Physiol Behav 2004, 81:149-155.
49. Riediger T., Schmid H.A., Lutz T., Simon E. Amylin potently activates AP neurons possibly via formation of the excitatory second messenger cGMP. Am J Physiol Regul Integr Comp Physiol 2001, 281:R1833-R1843.
50. Riediger T., Schmid H.A., Lutz T.A., Simon E. Amylin and glucose co-activate area postrema neurons of the rat. Neurosci Lett 2002, 328:121-124.
51. Riediger T., Zuend D., Becskei C., Lutz T.A. The anorectic hormone amylin contributes to feeding-related changes of neuronal activity in key structures of the gut-brain axis. Am J Physiol Regul Integr Comp Physiol 2004, 286:R114-R122.
52. Rowland N.E., Richmond R.M. Area postrema and the anorectic actions of dexfenfluramine and amylin. Brain Res 1999, 820:86-91.
53. Christopoulos G., Perry K.J., Morfis M., Tilakaratne N., Gao Y., Fraser N.J., et al. Multiple amylin receptors arise from receptor activity-modifying protein interaction with the calcitonin receptor gene product. Mol Pharmacol 1999, 56:235-242.
54. Muff R., Buhlmann N., Fischer J.A., Born W. An amylin receptor is revealed following co-transfection of a calcitonin receptor with receptor activity modifying proteins-1 or -3. Endocrinology 1999, 140:2924-2927.
55. Ueda T., Ugawa S., Saishin Y., Shimada S. Expression of receptor-activity modifying protein (RAMP) mRNAs in the mouse brain. Brain Res Mol Brain Res 2001, 93:36-45.
56. Barth S.W., Riediger T., Lutz T.A., Rechkemmer G. Peripheral amylin activates circumventricular organs expressing calcitonin receptor a/b subtypes and receptor-activity modifying proteins in the rat. Brain Res 2004, 997:97-102.
57. Potes C.S., Lutz T.A. Brainstem mechanisms of amylin-induced anorexia. Physiol Behav 2010, 100:511-518.
58. Potes C.S., Riediger T., Lutz T.A. Amylin induces ERK 1/2 phosphorylation in structures of the AP/NTS-LPB-Ce-BSTL axis. Appetite 2010, 54:670.
59. Rowland N.E., Crews E.C., Gentry R.M. Comparison of Fos induced in rat brain by GLP-1 and amylin. Regul Pept 1997, 71:171-174.
60. Potes C.S., Turek V.F., Cole R.L., Vu C., Roland B.L., Roth J.D., et al. Noradrenergic neurons of the area postrema mediate amylin's hypophagic action. Am J Physiol Regul Integr Comp Physiol 2010, 299:R623-R631.
61. Potes C.S., Lutz T.A., Riediger T. Identification of central projections from amylin-activated neurons to the lateral hypothalamus. Brain Res 2010, 1334:31-44.
62. Becskei C., Grabler V., Edwards G.L., Riediger T., Lutz T.A. Lesion of the lateral parabrachial nucleus attenuates the anorectic effect of peripheral amylin and CCK. Brain Res 2007, 1162:76-84.
63. Becskei C., Riediger T., Zund D., Wookey P., Lutz T.A. Immunohistochemical mapping of calcitonin receptors in the adult rat brain. Brain Res 2004, 1030:221-233.
64. Pieber T.R., Roitelman J., Lee Y., Luskey K.L., Stein D.T. Direct plasma radioimmunoassay for rat amylin-(1-37): concentrations with acquired and genetic obesity. Am J Physiol 1994, 267:E156-E164.
65. Leckstrom A., Lundquist I., Ma Z., Westermark P. Islet amyloid polypeptide and insulin relationship in a longitudinal study of the genetically obese (ob/ob) mouse. Pancreas 1999, 18:266-273.
66. Enoki S., Mitsukawa T., Takemura J., Nakazato M., Aburaya J., Toshimori H., et al. Plasma islet amyloid polypeptide levels in obesity, impaired glucose tolerance and non-insulin-dependent diabetes mellitus. Diab Res Clin Pract 1992, 15:97-102.
67. Hanabusa T., Kubo K., Oki C., Nakano Y., Okai K., Sanke T., et al. Islet amyloid polypeptide (IAPP) secretion from islet cells and its plasma concentration in patients with non-insulin-dependent diabetes mellitus. Diab Res Clin Pract 1992, 15:89-96.
68. Gloy V.L., Lutz T.A., Langhans W., Geary N., Hillebrand J.J. Basal plasma levels of insulin, leptin, ghrelin, and amylin do not signal adiposity in rats recovering from forced overweight. Endocrinology 2010, 151:4280-4288.
69. Wielinga P.Y., Lowenstein C., Muff S., Munz M., Woods S.C., Lutz T.A. Central amylin acts as an adiposity signal to control body weight and energy expenditure. Physiol Behav 2010, 101:45-52.
70. Rushing P.A., Hagan M.M., Seeley R.J., Lutz T.A., D'Alessio D.A., Air E.L. Inhibition of central amylin signaling increases food intake and body adiposity in rats. Endocrinology 2001, 142:5035.
71. Lutz T.A. Amylinergic control of food intake. Physiol Behav 2006, 89:465-471.
72. Lutz T.A. The role of amylin in the control of energy homeostasis. Am J Physiol Regul Integr Comp Physiol 2010, 298:R1475-R1484.
73. Osto M., Wielinga P.Y., Alder B., Walser N., Lutz T.A. Modulation of the satiating effect of amylin by central ghrelin, leptin and insulin. Physiol Behav 2007, 91:566-572.
74. Roth J.D., Roland B.L., Cole R.L., Trevaskis J.L., Weyer C., Koda J.E., et al. Leptin responsiveness restored by amylin agonism in diet-induced obesity: evidence from nonclinical and clinical studies. Proc Natl Acad Sci USA 2008, 105:7257-7262.
75. Trevaskis J., Coffey T., Cole R., Lei C., Wittmer C., Walsh B., et al. Amylin-mediated restoration of leptin responsiveness in diet-induced obesity: magnitude and mechanisms. Endocrinology 2008, 149:5679-5687.
76. Turek V.F., Trevaskis J.L., Levin B.E., Dunn-Meynell A.A., Irani B., Gu G., et al. Mechanisms of amylin/leptin synergy in rodent models. Endocrinology 2010, 151:143-152.
77. Mollet A., Meier S., Riediger T., Lutz T.A. Histamine H1 receptors in the ventromedial hypothalamus mediate the anorectic action of the pancreatic hormone amylin. Peptides 2003, 24:155-158.
78. Mollet A., Lutz T.A., Meier S., Riediger T., Rushing P.A., Scharrer E. Histamine H1 receptors mediate the anorectic action of the pancreatic hormone amylin. Am J Physiol Regul Integr Comp Physiol 2001, 281:R1442-R1448.
79. Morimoto T., Yamamoto Y., Mobarakeh J.I., Yanai K., Watanabe T., Yamatodani A. Involvement of the histaminergic system in leptin-induced suppression of food intake. Physiol Behav 1999, 67:679-683.
80. Trevaskis J.L., Parkes D.G., Roth J.D. Insights into amylin-leptin synergy. Trends Endocrinol Metab 2010, 21:473-479.
81. Boyle C.N., Munz M., Wielinga P.Y., Stöcker D., Lutz T.A. Short-term, but not extended, access to palatable diet diminishes amylin responsiveness in rat. Appetite 2010, 54:636.
82. Boyle C.N., Rossier M.M., Lutz T.A. Diet-induced obesity, hyperamylinemia and amylin sensitivity. Appetite 2010, 54:636.
83. Gedulin B.R., Young A.A. Hypoglycemia overrides amylin-mediated regulation of gastric emptying in rats. Diabetes 1998, 47:93-97.
84. Levin B.E., Dunn-Meynell A.A. Defense of body weight depends on dietary composition and palatability in rats with diet-induced obesity. Am J Physiol Regul Integr Comp Physiol 2002, 282:R46-R54.
85. Knight Z.A., Hannan K.S., Greenberg M.L., Friedman J.M. Hyperleptinemia is required for the development of leptin resistance. PLoS ONE 2010, 5:e11376.
86. Covasa M., Marcuson J.K., Ritter R.C. Diminished satiation in rats exposed to elevated levels of endogenous or exogenous cholecystokinin. Am J Physiol Regul Integr Comp Physiol 2001, 280:R331-R337.
87. Reinehr T., de Sousa G., Niklowitz P., Roth C.L. Amylin and its relation to insulin and lipids in obese children before and after weight loss. Obesity (Silver Spring) 2007, 15:2006-2011.
88. Banks W.A., Kastin A.J., Maness L.M., Huang W., Jaspan J.B. Permeability of the blood-brain barrier to amylin. Life Sci 1995, 57:1993-2001.
89. Banks W.A., Kastin A.J. Differential permeability of the blood-brain barrier to two pancreatic peptides: insulin and amylin. Peptides 1998, 19:883-889.
90. Banks W.A. The blood-brain barrier: connecting the gut and the brain. Regul Pept 2008, 149:11-14.
91. Butler P.C., Chou J., Carter W.B., Wang Y.N., Bu B.H., Chang D., et al. Effects of meal ingestion on plasma amylin concentration in NIDDM and nondiabetic humans. Diabetes 1990, 39:752-756.
92. Ogawa A., Harris V., McCorkle S.K., Unger R.H., Luskey K.L. Amylin secretion from the rat pancreas and its selective loss after streptozotocin treatment. J Clin Invest 1990, 85:973-976.
93. Qi D., Cai K., Wang O., Li Z., Chen J., Deng B., et al. Fatty acids induce amylin expression and secretion by pancreatic beta-cells. Am J Physiol Endocrinol Metab 2010, 289:E99-E107.
94. Pieber T.R., Stein D.T., Ogawa A., Alam T., Ohneda M., McCorkle K., et al. Amylin-insulin relationships in insulin resistance with and without diabetic hyperglycemia. Am J Physiol 1993, 265:E446-E453.
95. Blackard W.G., Clore J.N., Kellum J.M. Amylin/insulin secretory ratios in morbidly obese man: inverse relationship with glucose disappearance rate. J Clin Endocrinol Metab 1994, 78:1257-1260.
96. Riediger T., Hermann A., Hehl A., Bouret S.G., Lutz T.A., Riediger T., et al. Amylin deficient mice have decreased fiber density in AP-NTS projections. Appetite 2009, 52:854.
97. Bouret S.G. Development of hypothalamic neural networks controlling appetite. Forum Nutr 2010, 63:84-93.
98. Kelley A.E. Ventral striatal control of appetitive motivation: role in ingestive behavior and reward-related learning. Neurosci Biobehav Rev 2004, 27:765-776.
99. Stratford T.R., Kelley A.E. GABA in the nucleus accumbens shell participates in the central regulation of feeding behavior. J Neurosci 1997, 17:4434-4440.
100. Zhang M., Gosnell B.A., Kelley A.E. Intake of high-fat food is selectively enhanced by mu opioid receptor stimulation within the nucleus accumbens. J Pharmacol Exp Ther 1998, 285:908-914.
101. Baldo B.A., Sadeghian K., Basso A.M., Kelley A.E. Effects of selective dopamine D1 or D2 receptor blockade within nucleus accumbens subregions on ingestive behavior and associated motor activity. Behav Brain Res 2002, 137:165-177.
102. Baldo B.A., Kelley A.E. Discrete neurochemical coding of distinguishable motivational processes: insights from nucleus accumbens control of feeding. Psychopharmacology (Berl) 2007, 191:439-459.
103. Will M.J., Franzblau E.B., Kelley A.E. Nucleus accumbens mu-opioids regulate intake of a high-fat diet via activation of a distributed brain network. J Neurosci 2003, 23:2882-2888.
104. Kelley A.E., Baldo B.A., Pratt W.E. A proposed hypothalamic-thalamic-striatal axis for the integration of energy balance, arousal, and food reward. J Comp Neurol 2005, 493:72-85.
105. Kelley A.E., Berridge K.C. The neuroscience of natural rewards: relevance to addictive drugs. J Neurosci 2002, 22:3306-3311.
106. Ahn S., Phillips A.G. Dopaminergic correlates of sensory-specific satiety in the medial prefrontal cortex and nucleus accumbens of the rat. J Neurosci 1999, 19:RC29.
107. Rada P., Avena N.M., Hoebel B.G. Daily bingeing on sugar repeatedly releases dopamine in the accumbens shell. Neuroscience 2005, 134:737-744.
108. Geiger B.M., Haburcak M., Avena N.M., Moyer M.C., Hoebel B.G., Pothos E.N. Deficits of mesolimbic dopamine neurotransmission in rat dietary obesity. Neuroscience 2009, 159:1193-1199.
109. Geiger B.M., Behr G.G., Frank L.E., Caldera-Siu A.D., Beinfeld M.C., Kokkotou E.G., et al. Evidence for defective mesolimbic dopamine exocytosis in obesity-prone rats. FASEB J 2008, 22:2740-2746.
110. Hommel J.D., Trinko R., Sears R.M., Georgescu D., Liu Z.W., Gao X.B., et al. Leptin receptor signaling in midbrain dopamine neurons regulates feeding. Neuron 2006, 51:801-810.
111. Figlewicz D.P., Evans S.B., Murphy J., Hoen M., Baskin D.G. Expression of receptors for insulin and leptin in the ventral tegmental area/substantia nigra (VTA/SN) of the rat. Brain Res 2003, 964:107-115.
112. Fulton S., Pissios P., Manchon R.P., Stiles L., Frank L., Pothos E.N., et al. Leptin regulation of the mesoaccumbens dopamine pathway. Neuron 2006, 51:811-822.
113. Figlewicz D.P., Benoit S.C. Insulin, leptin, and food reward: update 2008. Am J Physiol Regul Integr Comp Physiol 2009, 296:R9-R19.
114. DiLeone R.J. The influence of leptin on the dopamine system and implications for ingestive behavior. Int J Obes (Lond) 2009, 33(Suppl 2):S25-S29.
115. Sexton P.M., Paxinos G., Kenney M.A., Wookey P.J., Beaumont K. In vitro autoradiographic localization of amylin binding sites in rat brain. Neuroscience 1994, 62:553-567.
116. van Rossum D., Hanisch U.K., Quirion R. Neuroanatomical localization, pharmacological characterization and functions of CGRP, related peptides and their receptors. Neurosci Biobehav Rev 1997, 21:649-678.
117. Veale P.R., Bhogal R., Morgan D.G., Smith D.M., Bloom S.R. The presence of islet amyloid polypeptide/calcitonin gene-related peptide/salmon calcitonin binding sites in the rat nucleus accumbens. Eur J Pharmacol 1994, 262:133-141.
118. Baldo B.A., Kelley A.E. Amylin infusion into rat nucleus accumbens potently depresses motor activity and ingestive behavior. Am J Physiol Regul Integr Comp Physiol 2001, 281:R1232-R1242.
119. Mack C., Wilson J., Athanacio J., Reynolds J., Laugero K., Guss S., et al. Pharmacological actions of the peptide hormone amylin in the long-term regulation of food intake, food preference, and body weight. Am J Physiol Regul Integr Comp Physiol 2007, 293:R1855-R1863.
120. Morley J.E., Suarez M.D., Mattamal M., Flood J.F. Amylin and food intake in mice: effects on motivation to eat and mechanism of action. Pharmacol Biochem Behav 1997, 56:123-129.